PREB
gene geneOn this page
Also known as SEC12
Summary
PREB (prolactin regulatory element binding, HGNC:9356) is a protein-coding gene on chromosome 2p23.3, encoding Guanine nucleotide-exchange factor SEC12 (Q9HCU5). Guanine nucleotide exchange factor (GEF) that regulates the assembly of the coat protein complex II/COPII in endoplasmic reticulum (ER) to Golgi vesicle-mediated transport. It is a common-essential gene (DepMap: required in 97.0% of cancer cell lines).
This gene encodes a protein that specifically binds to a Pit1-binding element of the prolactin (PRL) promoter. This protein may act as a transcriptional regulator and is thought to be involved in some of the developmental abnormalities observed in patients with partial trisomy 2p. This gene overlaps the abhydrolase domain containing 1 (ABHD1) gene on the opposite strand.
Source: NCBI Gene 10113 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 66 total
- Cancer dependency (DepMap): dependent in 97.0% of screened cell lines (common-essential)
- Transcription factor: yes — 26 downstream targets (CollecTRI)
- MANE Select transcript:
NM_013388
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9356 |
| Approved symbol | PREB |
| Name | prolactin regulatory element binding |
| Location | 2p23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SEC12 |
| Ensembl gene | ENSG00000138073 |
| Ensembl biotype | protein_coding |
| OMIM | 606395 |
| Entrez | 10113 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 16 protein_coding, 2 nonsense_mediated_decay, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000260643, ENST00000406567, ENST00000416802, ENST00000430533, ENST00000441451, ENST00000444452, ENST00000456259, ENST00000468045, ENST00000474802, ENST00000883719, ENST00000883720, ENST00000883721, ENST00000883722, ENST00000883723, ENST00000883724, ENST00000921642, ENST00000921643, ENST00000921644, ENST00000971833, ENST00000971834, ENST00000971835
RefSeq mRNA: 5 — MANE Select: NM_013388
NM_001330484, NM_001330485, NM_001330486, NM_001330487, NM_013388
CCDS: CCDS1738, CCDS82431
Canonical transcript exons
ENST00000260643 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000809079 | 27133532 | 27133721 |
| ENSE00001883623 | 27134287 | 27134636 |
| ENSE00003519541 | 27130756 | 27131508 |
| ENSE00003528995 | 27132843 | 27132923 |
| ENSE00003594519 | 27132010 | 27132082 |
| ENSE00003626364 | 27132230 | 27132403 |
| ENSE00003641231 | 27133117 | 27133337 |
| ENSE00003652563 | 27131672 | 27131831 |
| ENSE00003664128 | 27132603 | 27132727 |
Expression profiles
Bgee: expression breadth ubiquitous, 279 present calls, max score 96.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 30.0251 / max 115.3024, expressed in 1816 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 27448 | 27.1244 | 1815 |
| 27447 | 2.9007 | 1454 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 96.46 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.43 | gold quality |
| left uterine tube | UBERON:0001303 | 95.87 | gold quality |
| muscle of leg | UBERON:0001383 | 95.79 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.72 | gold quality |
| body of pancreas | UBERON:0001150 | 95.60 | gold quality |
| apex of heart | UBERON:0002098 | 95.33 | gold quality |
| body of uterus | UBERON:0009853 | 95.32 | gold quality |
| right ovary | UBERON:0002118 | 95.21 | gold quality |
| granulocyte | CL:0000094 | 94.63 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.54 | gold quality |
| adenohypophysis | UBERON:0002196 | 94.52 | gold quality |
| right atrium auricular region | UBERON:0006631 | 93.98 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 93.94 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.92 | gold quality |
| muscle organ | UBERON:0001630 | 93.75 | gold quality |
| pancreas | UBERON:0001264 | 93.73 | gold quality |
| left ovary | UBERON:0002119 | 93.72 | gold quality |
| minor salivary gland | UBERON:0001830 | 93.64 | gold quality |
| body of stomach | UBERON:0001161 | 93.61 | gold quality |
| islet of Langerhans | UBERON:0000006 | 93.55 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.41 | gold quality |
| heart left ventricle | UBERON:0002084 | 93.37 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.33 | gold quality |
| pituitary gland | UBERON:0000007 | 93.26 | gold quality |
| metanephros cortex | UBERON:0010533 | 93.13 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.09 | gold quality |
| spleen | UBERON:0002106 | 93.08 | gold quality |
| omental fat pad | UBERON:0010414 | 93.06 | gold quality |
| peritoneum | UBERON:0002358 | 93.01 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 18.59 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
26 targets.
| Target | Regulation |
|---|---|
| ABCA1 | Unknown |
| ADAM2 | |
| ADIPOQ | |
| ATP11C | |
| CCL2 | Unknown |
| CD19 | |
| CYP11B1 | |
| EPOR | |
| GCK | |
| GK | |
| IFNA1 | |
| IGLL1 | |
| IL7 | |
| INPPL1 | |
| INS | |
| POU1F1 | |
| PREB | |
| PRKACA | |
| PRL | Unknown |
| RAG2 | |
| RET | |
| SCARB1 | |
| SLC18A2 | |
| TRH | |
| UGT1A7 | |
| VPREB1 |
Upstream regulators (CollecTRI, top): EBF1, MAZ, NFKB, PBX1, POU1F1, PREB, REL, SPIC, TCF3
miRNA regulators (miRDB)
24 targeting PREB, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-1205 | 99.65 | 66.76 | 1826 |
| HSA-MIR-298 | 99.63 | 67.56 | 1916 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-4777-5P | 99.33 | 67.53 | 1148 |
| HSA-MIR-7160-5P | 99.11 | 67.17 | 2207 |
| HSA-MIR-4695-5P | 99.06 | 64.87 | 1151 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-3124-3P | 98.87 | 68.95 | 2123 |
| HSA-MIR-3074-5P | 98.82 | 66.56 | 1414 |
| HSA-MIR-4656 | 98.79 | 66.22 | 1306 |
| HSA-MIR-1910-3P | 98.44 | 67.51 | 1695 |
| HSA-MIR-6511A-5P | 98.13 | 67.47 | 1770 |
| HSA-MIR-1301-5P | 98.09 | 66.62 | 495 |
| HSA-MIR-6502-5P | 98.09 | 66.73 | 495 |
| HSA-MIR-6747-3P | 97.73 | 64.84 | 1596 |
| HSA-MIR-3620-5P | 97.42 | 63.95 | 792 |
| HSA-MIR-1587 | 96.95 | 64.03 | 932 |
| HSA-MIR-635 | 96.00 | 65.54 | 687 |
| HSA-MIR-6774-5P | 95.94 | 65.18 | 722 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 97.0% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 7)
- The transcriptional factor PREB mediates MCP-1 transcription induced by cytokines in human vascular endothelial cells. (PMID:19426980)
- PREB regulates the cAMP-mediated transcription of the ABCA1 gene in vascular smooth muscle cells (PMID:20643408)
- Sec12, a guanine-nucleotide exchange factor for Sar1 guanosine triphosphatase, is concentrated at endoplasmic reticulum exit sites and that this concentration of Sec12 is specifically required for the secretion of collagen VII but not other proteins. (PMID:25202031)
- These results indicate that PREB locates at the hepatitis C virus replication complex by interacting with NS4B. (PMID:26739056)
- Wls-SEC12 binding is stable, with the interacting interface biochemically mapped to cytosolic segments of individual proteins. Mutant Wls that fails to communicate with the COPII machinery cannot effectively support Wnt secretion. These data suggest that formation of early Wnt secretory vesicles is carefully regulated to ensure proper export of functional ligands (PMID:28515233)
- Administration of recombinant adenovirus containing human PREB to db/db, ob/ob, and DIO mice diminished glucose, insulin, and pyruvate tolerance indicating PREB to be a negative regulator of liver gluconeogenic genes. (PMID:29601978)
- Both cTAGE5 and SEC12 were exported with TANGO1 in large COPII carriers. (PMID:30545919)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | preb | ENSDARG00000101602 |
| mus_musculus | Preb | ENSMUSG00000045302 |
| rattus_norvegicus | Preb | ENSRNOG00000007141 |
| drosophila_melanogaster | CG9175 | FBGN0031779 |
| caenorhabditis_elegans | sec-12 | WBGENE00010496 |
Protein
Protein identifiers
Guanine nucleotide-exchange factor SEC12 — Q9HCU5 (reviewed: Q9HCU5)
Alternative names: Prolactin regulatory element-binding protein
All UniProt accessions (6): Q9HCU5, B5MC98, F8WCS5, H7BZX0, H7C0W3, H7C2N7
UniProt curated annotations — full annotation on UniProt →
Function. Guanine nucleotide exchange factor (GEF) that regulates the assembly of the coat protein complex II/COPII in endoplasmic reticulum (ER) to Golgi vesicle-mediated transport. Selectively activates SAR1A and SAR1B by promoting the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) in these small GTPases. In their activated GTP-bound state, SAR1A and SAR1B insert into the membrane of the endoplasmic reticulum where they recruit the remainder of the coat protein complex II/COPII which is responsible for both the sorting of proteins and the deformation and budding of membranes into vesicles destined to the Golgi. Was first identified based on its probable role in the regulation of pituitary gene transcription. Binds to the prolactin gene (PRL) promoter and seems to activate transcription.
Subunit / interactions. Interacts with SAR1B (GDP-bound form). Interacts with MIA2; recruits PREB to endoplasmic reticulum exit sites. Interacts with CIDEB; facilitating loading of SCAP-SREBP into COPII vesicles.
Subcellular location. Endoplasmic reticulum membrane. Nucleus.
Tissue specificity. Ubiquitous.
RefSeq proteins (5): NP_001317413, NP_001317414, NP_001317415, NP_001317416, NP_037520* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR011047 | Quinoprotein_ADH-like_sf | Homologous_superfamily |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR045260 | Sec12-like | Family |
Pfam: PF00400
UniProt features (51 total): strand 30, repeat 7, turn 4, topological domain 2, helix 2, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, sequence conflict 1, transmembrane region 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 5TF2 | X-RAY DIFFRACTION | 2.8 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HCU5-F1 | 88.33 | 0.75 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 10
Function
Pathways and Gene Ontology
Reactome pathways
14 pathways
| ID | Pathway |
|---|---|
| R-HSA-204005 | COPII-mediated vesicle transport |
| R-HSA-381038 | XBP1(S) activates chaperone genes |
| R-HSA-5694530 | Cargo concentration in the ER |
| R-HSA-199977 | ER to Golgi Anterograde Transport |
| R-HSA-199991 | Membrane Trafficking |
| R-HSA-2262752 | Cellular responses to stress |
| R-HSA-381070 | IRE1alpha activates chaperones |
| R-HSA-381119 | Unfolded Protein Response (UPR) |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-446203 | Asparagine N-linked glycosylation |
| R-HSA-5653656 | Vesicle-mediated transport |
| R-HSA-597592 | Post-translational protein modification |
| R-HSA-8953897 | Cellular responses to stimuli |
| R-HSA-948021 | Transport to the Golgi and subsequent modification |
MSigDB gene sets: 177 (showing top):
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR, TGCGCANK_UNKNOWN, GOBP_VESICLE_LOCALIZATION, GOBP_VESICLE_ORGANIZATION, GOBP_VESICLE_TARGETING, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOMF_GTPASE_BINDING, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, CAIRO_HEPATOBLASTOMA_CLASSES_DN, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT, TGCTGAY_UNKNOWN, GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY, GOBP_LIPOPROTEIN_LOCALIZATION, MYB_Q3
GO Biological Process (7): obsolete regulation of COPII vesicle coating (GO:0003400), endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), lipoprotein transport (GO:0042953), COPII vesicle coat assembly (GO:0048208), protein transport (GO:0015031), vesicle-mediated transport (GO:0016192), COPII-coated vesicle cargo loading (GO:0090110)
GO Molecular Function (4): DNA binding (GO:0003677), guanyl-nucleotide exchange factor activity (GO:0005085), GTPase binding (GO:0051020), protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), endoplasmic reticulum exit site (GO:0070971), endoplasmic reticulum (GO:0005783)
Reactome top-level categories
Rollup of top-11 pathways:
| Category | Pathways |
|---|---|
| ER to Golgi Anterograde Transport | 2 |
| IRE1alpha activates chaperones | 1 |
| Membrane Trafficking | 1 |
| Transport to the Golgi and subsequent modification | 1 |
| Vesicle-mediated transport | 1 |
| Cellular responses to stimuli | 1 |
| Unfolded Protein Response (UPR) | 1 |
| Cellular responses to stress | 1 |
| Post-translational protein modification | 1 |
| Metabolism of proteins | 1 |
| Asparagine N-linked glycosylation | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 2 |
| intracellular transport | 2 |
| COPII-coated vesicle budding | 2 |
| transport | 2 |
| intracellular membrane-bounded organelle | 2 |
| cellular anatomical structure | 2 |
| intercellular transport | 1 |
| Golgi vesicle transport | 1 |
| protein transport | 1 |
| lipoprotein localization | 1 |
| vesicle coat assembly | 1 |
| protein-containing complex assembly | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| cellular process | 1 |
| vesicle cargo loading | 1 |
| nucleic acid binding | 1 |
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| enzyme binding | 1 |
| binding | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| endoplasmic reticulum | 1 |
| endomembrane system | 1 |
Protein interactions and networks
STRING
1516 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PREB | MIA2 | Q96PC5 | 985 |
| PREB | SEC13 | P55735 | 972 |
| PREB | SEC24B | O95487 | 965 |
| PREB | SAR1A | Q9NR31 | 961 |
| PREB | SEC16A | O15027 | 948 |
| PREB | SAR1B | Q9Y6B6 | 917 |
| PREB | SEC31A | O94979 | 895 |
| PREB | SEC24A | O95486 | 883 |
| PREB | ABHD1 | Q96SE0 | 854 |
| PREB | RER1 | O15258 | 833 |
| PREB | SEC23A | Q15436 | 827 |
| PREB | MIA3 | Q5JRA6 | 785 |
| PREB | SEC24D | O94855 | 780 |
| PREB | GOLPH3 | Q9H4A6 | 776 |
| PREB | SEC23B | Q15437 | 770 |
IntAct
134 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| SLC39A5 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.640 |
| OCLN | DNAJC13 | psi-mi:“MI:0914”(association) | 0.530 |
| ANO6 | CDC27 | psi-mi:“MI:0914”(association) | 0.530 |
| XPO1 | psi-mi:“MI:0914”(association) | 0.530 | |
| ANO4 | ANO6 | psi-mi:“MI:0914”(association) | 0.530 |
| SIDT2 | AP3D1 | psi-mi:“MI:0914”(association) | 0.530 |
| MIA2 | MIA3 | psi-mi:“MI:0914”(association) | 0.530 |
| ANKH | FAM234B | psi-mi:“MI:0914”(association) | 0.530 |
| SLC6A8 | ILVBL | psi-mi:“MI:0914”(association) | 0.530 |
| UNC93B1 | GPR89A | psi-mi:“MI:0914”(association) | 0.530 |
| NRAS | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.480 |
| vpu | SCAMP3 | psi-mi:“MI:0914”(association) | 0.460 |
| GTPBP4 | PREB | psi-mi:“MI:0915”(physical association) | 0.400 |
| Preb | PREB | psi-mi:“MI:0915”(physical association) | 0.400 |
| HSP90AB1 | PREB | psi-mi:“MI:0915”(physical association) | 0.400 |
| NUDC | PREB | psi-mi:“MI:0915”(physical association) | 0.400 |
| psi-mi:“MI:0914”(association) | 0.350 | ||
| ESYT2 | psi-mi:“MI:0914”(association) | 0.350 | |
| E5 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| HAX1 | psi-mi:“MI:0914”(association) | 0.350 | |
| BVLF1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (252): PREB (Proximity Label-MS), PREB (Proximity Label-MS), PREB (Proximity Label-MS), PREB (Proximity Label-MS), PREB (Proximity Label-MS), PREB (Proximity Label-MS), PREB (Proximity Label-MS), PREB (Affinity Capture-MS), PREB (Affinity Capture-MS), PREB (Affinity Capture-MS), PREB (Affinity Capture-MS), PREB (Affinity Capture-Western), PREB (Affinity Capture-MS), PREB (Affinity Capture-MS), PREB (Affinity Capture-MS)
ESM2 similar proteins: A0A1D5PJB7, A0A1L8HX76, A6QR40, O08764, O60294, O95382, P10938, P70218, P97452, Q12851, Q14137, Q15334, Q16586, Q28686, Q32P44, Q3TJ91, Q499N3, Q499U2, Q4KLI9, Q561R2, Q562C2, Q5RBH8, Q5RCX2, Q61161, Q6AY79, Q6F5E8, Q6P1M3, Q6V7V2, Q7SZE3, Q7TMC8, Q80Y17, Q8BYZ7, Q8C3I8, Q8C6B2, Q8CHW4, Q8K4K5, Q8MKF0, Q8N0W3, Q8VC03, Q91WI7
Diamond homologs: A4D1P6, B2RYI0, Q05B30, Q2HJE1, Q5F3D7, Q5R6T6, Q5ZLL7, Q6TEN6, Q7TMQ7, Q9HCU5, Q9WTV0, Q9WUQ2, Q23533, Q68FJ6, Q54PE0, Q5R4T8, Q8VDD9, Q8WWQ0, A0CH87, A0DB19, A1CF18, A1CUD6, A1DP19, A2QP30, A4R3M4, A7EKM8, B0XM00, B2AEZ5, B2B766, B6GZD3, B6HP56, B6QC06, B6QC56, B8M0Q1, B8N9H4, B8P4B0, B8PD53, C0NRC6, C0S902, C1GB49
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| LTK | “down-regulates activity” | PREB | phosphorylation |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 162 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Amino acid transport across the plasma membrane | 7 | 18.4× | 6e-05 |
| R-HSA-425366 | 6 | 9.5× | 8e-03 |
| SLC-mediated transmembrane transport | 11 | 5.7× | 1e-03 |
| Transport of small molecules | 15 | 3.3× | 8e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| amino acid transport | 9 | 19.8× | 8e-07 |
| chloride transmembrane transport | 6 | 10.0× | 5e-03 |
| transport across blood-brain barrier | 7 | 8.8× | 3e-03 |
| response to ethanol | 7 | 7.2× | 7e-03 |
| response to xenobiotic stimulus | 10 | 4.9× | 6e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
66 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 46 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1440 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:27131670:A:AC | donor_gain | 1.0000 |
| 2:27131670:ACGC:A | donor_gain | 1.0000 |
| 2:27131671:C:CC | donor_gain | 1.0000 |
| 2:27131671:CG:C | donor_gain | 1.0000 |
| 2:27131671:CGCC:C | donor_gain | 1.0000 |
| 2:27131671:CGCCG:C | donor_gain | 1.0000 |
| 2:27131828:GGCA:G | acceptor_gain | 1.0000 |
| 2:27131828:GGCAC:G | acceptor_loss | 1.0000 |
| 2:27131829:GCAC:G | acceptor_loss | 1.0000 |
| 2:27131830:CA:C | acceptor_gain | 1.0000 |
| 2:27131831:AC:A | acceptor_loss | 1.0000 |
| 2:27131832:C:CC | acceptor_gain | 1.0000 |
| 2:27131832:CTGT:C | acceptor_loss | 1.0000 |
| 2:27131833:T:C | acceptor_loss | 1.0000 |
| 2:27132079:TTCA:T | acceptor_gain | 1.0000 |
| 2:27132080:TCA:T | acceptor_gain | 1.0000 |
| 2:27132081:CA:C | acceptor_gain | 1.0000 |
| 2:27132081:CAC:C | acceptor_gain | 1.0000 |
| 2:27132083:C:CC | acceptor_gain | 1.0000 |
| 2:27132227:CA:C | donor_gain | 1.0000 |
| 2:27132228:A:AT | donor_loss | 1.0000 |
| 2:27132254:T:TA | donor_gain | 1.0000 |
| 2:27132404:CTGGG:C | acceptor_loss | 1.0000 |
| 2:27132723:ACCAA:A | acceptor_gain | 1.0000 |
| 2:27132724:CCAA:C | acceptor_gain | 1.0000 |
| 2:27132724:CCAAC:C | acceptor_gain | 1.0000 |
| 2:27132725:CAAC:C | acceptor_gain | 1.0000 |
| 2:27132726:AA:A | acceptor_gain | 1.0000 |
| 2:27132727:AC:A | acceptor_loss | 1.0000 |
| 2:27132728:C:CC | acceptor_gain | 1.0000 |
AlphaMissense
2675 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:27132303:A:G | W285R | 0.992 |
| 2:27132303:A:T | W285R | 0.992 |
| 2:27134293:A:C | N43K | 0.992 |
| 2:27134293:A:T | N43K | 0.992 |
| 2:27133609:G:T | A83D | 0.991 |
| 2:27134380:G:C | F14L | 0.991 |
| 2:27134380:G:T | F14L | 0.991 |
| 2:27134382:A:G | F14L | 0.991 |
| 2:27134327:C:T | G32D | 0.989 |
| 2:27131719:G:A | S371F | 0.988 |
| 2:27133122:A:G | W181R | 0.988 |
| 2:27133122:A:T | W181R | 0.988 |
| 2:27133717:A:G | F47S | 0.988 |
| 2:27132019:G:C | F330L | 0.987 |
| 2:27132019:G:T | F330L | 0.987 |
| 2:27132021:A:G | F330L | 0.987 |
| 2:27132301:C:A | W285C | 0.987 |
| 2:27132301:C:G | W285C | 0.987 |
| 2:27134330:G:T | A31E | 0.987 |
| 2:27132038:A:T | V324D | 0.986 |
| 2:27134294:T:A | N43I | 0.986 |
| 2:27131708:C:G | D375H | 0.985 |
| 2:27131707:T:A | D375V | 0.983 |
| 2:27131719:G:T | S371Y | 0.983 |
| 2:27133148:C:T | G172E | 0.983 |
| 2:27133714:A:G | L48P | 0.983 |
| 2:27131778:A:C | F351L | 0.982 |
| 2:27131778:A:T | F351L | 0.982 |
| 2:27131779:A:G | F351S | 0.982 |
| 2:27131780:A:G | F351L | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000375652 (2:27136241 C>A,T), RS1000427670 (2:27130334 A>T), RS1000700536 (2:27134783 A>T), RS1000767687 (2:27135956 T>C,G), RS1001454647 (2:27131710 A>C), RS1004230572 (2:27134116 C>T), RS1004661271 (2:27132885 G>A), RS1005226287 (2:27134766 A>C,G), RS1005546038 (2:27134626 A>C,G,T), RS1006330305 (2:27131570 C>A), RS1006950537 (2:27135698 C>A), RS1007113855 (2:27135391 C>G), RS1007684615 (2:27133449 C>G,T), RS1008960811 (2:27133230 G>A), RS1009414309 (2:27134658 G>A,C,T)
Disease associations
OMIM: gene MIM:606395 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010697_14 | Cortical surface area (min-P) | 2.000000e-09 |
| GCST010698_75 | Subcortical volume (min-P) | 2.000000e-13 |
| GCST010699_41 | Brain morphology (min-P) | 2.000000e-08 |
| GCST010700_38 | Cortical thickness (MOSTest) | 3.000000e-08 |
| GCST010701_56 | Cortical surface area (MOSTest) | 4.000000e-16 |
| GCST010702_20 | Subcortical volume (MOSTest) | 2.000000e-64 |
| GCST010703_76 | Brain morphology (MOSTest) | 1.000000e-16 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression, increases methylation | 3 |
| Cyclosporine | increases expression | 3 |
| bisphenol A | affects expression, decreases expression | 2 |
| Air Pollutants | affects cotreatment, increases abundance, increases expression, affects expression | 2 |
| Ozone | affects cotreatment, increases expression, increases abundance, affects expression | 2 |
| bisphenol F | increases expression | 1 |
| alpha-pinene | increases expression, increases abundance, affects cotreatment | 1 |
| pirinixic acid | increases activity, increases expression, affects binding | 1 |
| ochratoxin A | decreases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| methacrylaldehyde | affects cotreatment, increases expression, increases abundance | 1 |
| beta-methylcholine | affects expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| bisphenol B | increases expression | 1 |
| bisphenol S | affects cotreatment, increases expression | 1 |
| jinfukang | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Acrolein | affects cotreatment, increases expression, increases abundance | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Doxorubicin | affects expression | 1 |
| Indomethacin | increases expression, affects cotreatment | 1 |
| Ivermectin | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tunicamycin | increases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A5Q8 | SEES3-1V human PREB, clone1 | Embryonic stem cell | Male |
| CVCL_A5Q9 | SEES3-1V human PREB, clone2 | Embryonic stem cell | Male |
| CVCL_A5R0 | SEES3-1V human PREB, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.